Viewing Study NCT03013504


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-27 @ 3:00 PM
Study NCT ID: NCT03013504
Status: COMPLETED
Last Update Posted: 2024-11-06
First Post: 2016-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients
Sponsor: Prestige Biopharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module